marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Heron Therapeutics Financial Ratios 2011-2024 | HRTX
Annual Financial Ratios Heron Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.9 | -1.1 | -0.0 | -6.9 | -8.6 | -11.0 | -6.3 | -2.7 | -7.1 | -2.7 | -3.5 | -8.3 | -2.9 |
P/S |
2.6 | 1.9 | 0.0 | 17.8 | 12.0 | 25.5 | 40.1 | 372.1 | - | - | - | - | 52.1 |
EPS |
-0.8 | -1.7 | -2.2 | -2.5 | -2.5 | -2.4 | -3.6 | -4.6 | -3.0 | -2.9 | -3.4 | -1.9 | -2.0 |
EV (Enterprise Value) |
554 M | 428 M | 138 M | 1.59 B | 1.79 B | 2.03 B | 1.19 B | 551 M | 639 M | 151 M | 126 M | 144 M | 19.4 M |
EBITDA per Share |
-0.78 | -1.58 | -2.18 K | -2.48 | -2.55 | -2.49 | -3.57 | -4.48 | -2.91 | -2.78 | -3.35 | -1.93 | -1.81 |
EV/EBITDA |
-4.3 | -6.6 | -8.1 | -10.7 | -5.8 | -3.0 | -6.5 | -1.9 | -2.2 | -5.9 | -1.5 | ||
PEG |
-0.0 | -0.0 | -0.0 | 3.07 | -3.48 | 0.33 | 0.31 | -0.05 | -2.55 | 0.17 | -0.05 | 0.49 | 0.06 |
P/B |
-9.6 | 15.2 | 0.0 | 6.7 | 4.3 | 5.3 | 9.4 | -22.4 | 5.9 | 3.3 | 2.8 | 3.7 | 2.1 |
P/CF |
-5.5 | -1.4 | -0.0 | -8.2 | -13.3 | -9.8 | -7.1 | -3.5 | -8.7 | -3.4 | -4.5 | -10.7 | -4.1 |
ROE % |
325.43 | -1341.17 | -284.50 | -96.10 | -50.70 | -48.31 | -150.59 | 814.75 | -82.63 | -121.10 | -80.18 | -45.06 | -75.00 |
ROA % |
-49.69 | -72.53 | -72.19 | -64.28 | -39.93 | -38.69 | -84.28 | -256.58 | -70.80 | -99.59 | -72.80 | -41.71 | -60.76 |
ROCE % |
325.60 | -1286.90 | -280.81 | -90.88 | -50.64 | -49.69 | -148.36 | -594.51 | -82.06 | -118.23 | -78.99 | -45.99 | -70.23 |
Current Ratio |
0.9 | 1.1 | 1.3 | 3.1 | 5.0 | 4.9 | 2.2 | 1.6 | 6.8 | 5.4 | 10.4 | 13.0 | 4.9 |
DSO |
161.2 | 148.4 | 163.5 | 172.3 | 99.7 | 304.6 | 496.8 | 559.3 | - | - | - | - | - |
DIO |
271.0 | 342.4 | 358.0 | 422.7 | 147.9 | 517.8 | 804.1 | 55688.6 | - | - | - | - | - |
DPO |
18.1 | 23.4 | 17.2 | 6.3 | 18.2 | 226.7 | 1504.9 | 81895.6 | - | - | - | - | - |
Operating Cycle |
432.2 | 490.8 | 521.5 | 595.0 | 247.6 | 822.4 | 1300.9 | 56247.9 | - | - | - | - | - |
Cash Conversion Cycle |
414.1 | 467.4 | 504.4 | 588.6 | 229.4 | 595.7 | -204.0 | -25647.7 | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Heron Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.03 | -0.06 | -0.02 | -0.17 | -0.35 | -0.27 | - | -0.38 | -0.55 | -0.63 | - | -0.51 | -0.62 | -0.58 | -0.68 | -0.64 | -0.61 | -0.57 | -0.65 | -0.42 | -0.63 | -0.8 | -0.63 | -0.49 | -0.54 | -0.81 | -1.09 | -0.77 | -0.8 | -1 | -1.22 | -1.24 | -1.17 | -0.92 | -0.87 | -0.63 | -0.74 | -0.7 | -0.71 | -0.66 | -0.78 | -0.74 | -0.75 | -0.84 | -1.01 | -0.85 | -0.51 | -0.45 | -0.46 | -0.85 | -0.02 | -0.02 | -0.05 | -0.04 |
EBITDA per Share |
- | - | -0.03 | - | - | -0.27 | - | -0.36 | -0.47 | -0.61 | - | -0.49 | -0.6 | -0.56 | -0.67 | -0.62 | -0.6 | -0.58 | -0.66 | -0.42 | -0.64 | -0.82 | -0.66 | -0.52 | -0.53 | -0.8 | - | -0.74 | -0.77 | -0.97 | - | -1.2 | -1.15 | -0.91 | - | -0.61 | -0.73 | -0.69 | - | -0.64 | -0.76 | -0.73 | - | -0.81 | -0.99 | -0.83 | - | -0.02 | -21.4 | -0.02 | - | - | - | - |
ROE % |
135.82 | 230.77 | 493.13 | 297.10 | 20.43 | 172.65 | -194.05 | -238.15 | -95.57 | -392.97 | -109.02 | -135.35 | -115.88 | -101.11 | -96.10 | -84.11 | -67.81 | -56.91 | -50.70 | -49.75 | -51.79 | -49.80 | -48.31 | -82.58 | -104.14 | -126.34 | -150.59 | 122.76 | 382.95 | 618.99 | 814.75 | 562.60 | 315.14 | 92.17 | -82.63 | -88.88 | -100.12 | -110.70 | -121.10 | -108.76 | -97.00 | -89.21 | -80.18 | -74.75 | -67.89 | -54.35 | -60.56 | -72.68 | -87.54 | -90.99 | -75.00 | -26.68 | -12.27 | -9.01 |
ROA % |
-18.79 | -37.50 | -48.10 | -62.06 | -66.56 | -68.76 | -61.85 | -76.72 | -76.19 | -68.18 | -46.89 | -64.50 | -66.10 | -66.62 | -64.28 | -57.96 | -48.05 | -42.23 | -39.93 | -39.36 | -41.10 | -39.67 | -38.69 | -54.64 | -64.21 | -74.11 | -84.28 | -128.69 | -182.71 | -228.50 | -256.58 | -208.17 | -152.73 | -105.44 | -70.80 | -75.03 | -83.61 | -91.64 | -99.59 | -91.19 | -83.11 | -78.61 | -72.80 | -68.13 | -62.11 | -49.98 | -56.06 | -64.15 | -74.83 | -76.60 | -60.76 | -21.61 | -9.94 | -7.30 |
ROCE % |
132.06 | 228.85 | 501.16 | 300.39 | 24.12 | 143.90 | -221.47 | -264.98 | -121.93 | -387.42 | -107.83 | -133.75 | -114.93 | -100.74 | -96.48 | -85.26 | -69.20 | -58.45 | -52.17 | -51.34 | -53.99 | -51.67 | -49.69 | -67.33 | -87.55 | -109.12 | -101.17 | 123.45 | 379.58 | 614.30 | 584.03 | 564.99 | 321.32 | 99.18 | -55.77 | -85.82 | -96.83 | -107.14 | -87.32 | -105.69 | -94.00 | -86.26 | -58.92 | -70.61 | -63.92 | -50.31 | -29.34 | -55.30 | -69.57 | -70.90 | -44.08 | -25.96 | -9.78 | -8.35 |
Current Ratio |
0.8 | 0.8 | 0.9 | 0.9 | 0.8 | 0.9 | 1.1 | 1.1 | 0.9 | 1.1 | 1.3 | 1.5 | 1.7 | 2.7 | 3.0 | 3.0 | 3.0 | 3.0 | 4.7 | 4.7 | 4.7 | 4.7 | 5.0 | 5.0 | 5.0 | 5.0 | 2.3 | 3.0 | 3.2 | 2.7 | 0.8 | 0.8 | 0.8 | 0.8 | 7.0 | 7.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.6 | 5.3 | 7.5 | 6.0 | - |
DSO |
195.7 | 176.1 | 169.9 | 203.9 | 184.1 | 159.4 | - | 141.7 | 134.4 | 149.0 | - | 168.3 | 164.9 | 183.2 | 185.3 | 191.3 | 168.5 | 146.8 | 103.7 | 85.4 | 99.3 | 150.9 | 204.5 | 298.2 | 341.5 | 420.2 | 380.1 | 445.8 | 449.0 | 550.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
428.4 | 370.2 | 456.5 | 217.1 | 218.8 | 288.7 | - | 352.0 | 332.2 | 421.3 | - | 338.9 | 268.4 | 418.9 | 407.1 | 533.3 | 424.6 | 287.2 | 143.5 | 132.5 | 167.7 | 195.2 | 307.8 | 470.1 | 680.9 | 715.6 | 689.4 | 877.6 | 910.5 | 594.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
98.5 | 48.0 | 14.6 | 9.6 | 13.6 | 19.7 | - | 63.1 | 62.1 | 48.3 | - | 68.8 | 40.6 | 11.0 | 5.1 | 6.7 | 5.3 | 14.1 | 15.8 | 14.6 | 18.5 | 59.8 | 133.0 | 203.1 | 294.2 | 518.9 | 1280.0 | 1629.6 | 1690.7 | 984.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
624.2 | 546.2 | 626.4 | 421.0 | 402.9 | 448.1 | - | 493.8 | 466.7 | 570.3 | - | 507.2 | 433.4 | 602.1 | 592.5 | 724.6 | 593.1 | 434.1 | 247.2 | 217.9 | 266.9 | 346.1 | 512.3 | 768.3 | 1022.4 | 1135.8 | 1069.4 | 1323.3 | 1359.5 | 1144.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
525.7 | 498.3 | 611.8 | 411.4 | 389.3 | 428.4 | - | 430.7 | 404.5 | 522.0 | - | 438.3 | 392.7 | 591.1 | 587.4 | 717.9 | 587.8 | 419.9 | 231.4 | 203.2 | 248.4 | 286.2 | 379.3 | 565.2 | 728.2 | 616.9 | -210.6 | -306.2 | -331.2 | 160.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency